February 9th, 2023 – South San Francisco, CA Genetech Press Release New Phase III Data Show Genentech’s Vabysmo Rapidly Improved Vision and Reduced Retinal Fluid in People With Retinal Vein Occlusion (RVO) Vabysmo met its primary endpoint in two clinical…